Overexpression of transcription factor AP-2 stimulates the PA promoter of the human uracil-DNA glycosylase (UNG) gene through a mechanism involving derepression

DNA Repair

Volumn 8, Issue 7, 2009, Pages 822-833

  Aas, Per Arne ^a   Peña Diaz, Javier ^a   Liabakk, Nina Beate ^a   Krokan, Hans E ^a   Skorpen, Frank ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

AP 2; UNG; Uracil DNA glycosylase

Indexed keywords

LUCIFERASE; MESSENGER RNA; TRANSCRIPTION FACTOR AP 2; URACIL DNA GLYCOSIDASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; DEPRESSION; DIMERIZATION; DNA BINDING; GEL MOBILITY SHIFT ASSAY; GENE; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REPORTER GENE;

BASE SEQUENCE; BINDING SITES; CCAAT-BINDING FACTOR; CELL NUCLEUS; DEOXYRIBONUCLEASE I; DNA FOOTPRINTING; E2F TRANSCRIPTION FACTORS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HELA CELLS; HUMANS; LUCIFERASES; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTOR AP-2; TRANSFECTION; TRETINOIN; URACIL-DNA GLYCOSIDASE;

EID: 67349172695     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2009.03.008     Document Type: Article

References (51)

1. Krokan H.E., Otterlei M., Nilsen H., Kavli B., Skorpen F., Andersen S., Skjelbred C., Akbari M., Aas P.A., and Slupphaug G. Properties and functions of human uracil-DNA glycosylase from the UNG gene. Prog. Nucleic Acid Res. Mol. Biol. 68 (2001) 365-386
2. Kavli B., Sundheim O., Akbari M., Otterlei M., Nilsen H., Skorpen F., Aas P.A., Hagen L., Krokan H.E., and Slupphaug G. hUNG2 is the major repair enzyme for removal of uracil from U:A matches, U:G mismatches, and U in single-stranded DNA, with hSMUG1 as a broad specificity backup. J. Biol. Chem. 277 (2002) 39926-39936
3. Nilsen H., Stamp G., Andersen S., Hrivnak G., Krokan H.E., Lindahl T., and Barnes D.E. Gene-targeted mice lacking the Ung uracil-DNA glycosylase develop B-cell lymphomas. Oncogene 22 (2003) 5381-5386
4. Imai K., Slupphaug G., Lee W.I., Revy P., Nonoyama S., Catalan N., Yel L., Forveille M., Kavli B., Krokan H.E., Ochs H.D., Fischer A., and Durandy A. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 4 (2003) 1023-1028
5. Haug T., Skorpen F., Kvaloy K., Eftedal I., Lund H., and Krokan H.E. Human uracil-DNA glycosylase gene: sequence organization, methylation pattern, and mapping to chromosome 12q23-q24.1. Genomics 36 (1996) 408-416
6. Nilsen H., Otterlei M., Haug T., Solum K., Nagelhus T.A., Skorpen F., and Krokan H.E. Nuclear and mitochondrial uracil-DNA glycosylases are generated by alternative splicing and transcription from different positions in the UNG gene. Nucleic Acids Res. 25 (1997) 750-755
7. Haug T., Skorpen F., Aas P.A., Malm V., Skjelbred C., and Krokan H.E. Regulation of expression of nuclear and mitochondrial forms of human uracil-DNA glycosylase. Nucleic Acids Res. 26 (1998) 1449-1457
8. Haug T., Skorpen F., Lund H., and Krokan H.E. Structure of the gene for human uracil-DNA glycosylase and analysis of the promoter function. FEBS Lett. 353 (1994) 180-184
9. Muller-Weeks S., Balzer R.J., Anderson R., and Caradonna S. Proliferation-dependent expression of nuclear uracil-DNA glycosylase is mediated in part by E2F-4. DNA Repair (Amst.) 4 (2005) 183-190
10. Buettner R., Kannan P., Imhof A., Bauer R., Yim S.O., Glockshuber R., Van Dyke M.W., and Tainsky M.A. An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol. Cell Biol. 13 (1993) 4174-4185
11. Wankhade S., Yu Y., Weinberg J., Tainsky M.A., and Kannan P. Characterization of the activation domains of AP-2 family transcription factors. J. Biol. Chem. 275 (2000) 29701-29708
12. Tanaka M., Lai J.S., and Herr W. Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. Cell 68 (1992) 755-767
13. Krokan H., and Wittwer C.U. Uracil DNA-glycosylase from HeLa cells: general properties, substrate specificity and effect of uracil analogs. Nucleic Acids Res. 9 (1981) 2599-2613
14. Schreiber E., Matthias P., Muller M.M., and Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17 (1989) 6419
15. Beger M., Butz K., Denk C., Williams T., Hurst H.C., and Hoppe-Seyler F. Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcription. J. Mol. Med. 79 (2001) 314-320
16. Mitchell P.J., Wang C., and Tjian R. Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell 50 (1987) 847-861
17. Luscher B., Mitchell P.J., Williams T., and Tjian R. Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. Genes Dev. 3 (1989) 1507-1517
18. Oulad-Abdelghani M., Bouillet P., Chazaud C., Dolle P., and Chambon P. AP-2.2: a novel AP-2-related transcription factor induced by retinoic acid during differentiation of P19 embryonal carcinoma cells. Exp. Cell Res. 225 (1996) 338-347
19. Moser M., Imhof A., Pscherer A., Bauer R., Amselgruber W., Sinowatz F., Hofstadter F., Schule R., and Buettner R. Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. Development 121 (1995) 2779-2788
20. Williamson J.A., Bosher J.M., Skinner A., Sheer D., Williams T., and Hurst H.C. Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors. Genomics 35 (1996) 262-264
21. Roy A.L., Meisterernst M., Pognonec P., and Roeder R.G. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature 354 (1991) 245-248
22. Roy A.L., Du H., Gregor P.D., Novina C.D., Martinez E., and Roeder R.G. Cloning of an inr- and E-box-binding protein, TFII-I, that interacts physically and functionally with USF1. EMBO J. 16 (1997) 7091-7104
23. Ayer D.E., Kretzner L., and Eisenman R.N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72 (1993) 211-222
24. Blackwood E.M., and Eisenman R.N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251 (1991) 1211-1217
25. Zervos A.S., Gyuris J., and Brent R. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72 (1993) 223-232
26. Giangrande P.H., Hallstrom T.C., Tunyaplin C., Calame K., and Nevins J.R. Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor. Mol. Cell Biol. 23 (2003) 3707-3720
27. Williams T., Admon A., Luscher B., and Tjian R. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev. 2 (1988) 1557-1569
28. Williams T., and Tjian R. Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev. 5 (1991) 670-682
29. Imagawa M., Chiu R., and Karin M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51 (1987) 251-260
30. Schorle H., Meier P., Buchert M., Jaenisch R., and Mitchell P.J. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 381 (1996) 235-238
31. Zhang J., Hagopian-Donaldson S., Serbedzija G., Elsemore J., Plehn-Dujowich D., McMahon A.P., Flavell R.A., and Williams T. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 381 (1996) 238-241
32. Nottoli T., Hagopian-Donaldson S., Zhang J., Perkins A., and Williams T. AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 13714-13719
33. Bosher J.M., Williams T., and Hurst H.C. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 744-747
34. Turner B.C., Zhang J., Gumbs A.A., Maher M.G., Kaplan L., Carter D., Glazer P.M., Hurst H.C., Haffty B.G., and Williams T. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res. 58 (1998) 5466-5472
35. Williams T., and Tjian R. Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins. Science 251 (1991) 1067-1071
36. Zeng Y.X., Somasundaram K., and el-Deiry W.S. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat. Genet. 15 (1997) 78-82
37. McPherson L.A., Baichwal V.R., and Weigel R.J. Identification of ERF-1 as a member of the AP2 transcription factor family. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4342-4347
38. Huang S., Jean D., Luca M., Tainsky M.A., and Bar-Eli M. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. EMBO J. 17 (1998) 4358-4369
39. Greco D., Zellmer E., Zhang Z., and Lewis E. Transcription factor AP-2 regulates expression of the dopamine beta-hydroxylase gene. J. Neurochem. 65 (1995) 510-516
40. Gaubatz S., Imhof A., Dosch R., Werner O., Mitchell P., Buettner R., and Eilers M. Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J. 14 (1995) 1508-1519
41. Wu F., and Lee A.S. CDP and AP-2 mediated repression mechanism of the replication-dependent hamster histone H3.2 promoter. J. Cell Biochem. 84 (2002) 699-707
42. Slupphaug G., Olsen L.C., Helland D., Aasland R., and Krokan H.E. Cell cycle regulation and in vitro hybrid arrest analysis of the major human uracil-DNA glycosylase. Nucleic Acids Res. 19 (1991) 5131-5137
43. Sporn M.B., Roberts A.B., and Goodman D.S. The Retinoids Biology, Chemistry, and Medicine (1994), Raven Press, New York
44. Batsche E., Muchardt C., Behrens J., Hurst H.C., and Cremisi C. RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol. Cell Biol. 18 (1998) 3647-3658
45. Vergeer W.P., Sogo J.M., Pretorius P.J., and de Vries W.N. Interaction of Ap1, Ap2, and Sp1 with the regulatory regions of the human pro-alpha1(I) collagen gene. Arch. Biochem. Biophys. 377 (2000) 69-79
46. Ye J., Young H.A., Zhang X., Castranova V., Vallyathan V., and Shi X. Regulation of a cell type-specific silencer in the human interleukin-3 gene promoter by the transcription factor YY1 and an AP2 sequence-recognizing factor. J. Biol. Chem. 274 (1999) 26661-26667
47. Ye J., Cippitelli M., Dorman L., Ortaldo J.R., and Young H.A. The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element. Mol. Cell Biol. 16 (1996) 4744-4753
48. Wu F., and Lee A.S. YY1 as a regulator of replication-dependent hamster histone H3.2 promoter and an interactive partner of AP-2. J. Biol. Chem. 276 (2001) 28-34
49. Zhang D., Vuocolo S., Masciullo V., Sava T., Giordano A., Soprano D.R., and Soprano K.J. Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression. Oncogene 20 (2001) 7935-7944
50. Getman D.K., Mutero A., Inoue K., and Taylor P. Transcription factor repression and activation of the human acetylcholinesterase gene. J. Biol. Chem. 270 (1995) 23511-23519
51. Chen T.T., Wu R.L., Castro-Munozledo F., and Sun T.T. Regulation of K3 keratin gene transcription by Sp1 and AP-2 in differentiating rabbit corneal epithelial cells. Mol. Cell Biol. 17 (1997) 3056-3064